Inhibitors of type III secretion in Yersinia: design, synthesis and multivariate QSAR of 2-arylsulfonylamino-benzanilides

…, HA Norberg, C Sundin, A Linusson, M Elofsson

Index: Kauppi, Anna M.; Andersson, C. David; Norberg, Henrik A.; Sundin, Charlotta; Linusson, Anna; Elofsson, Mikael Bioorganic and Medicinal Chemistry, 2007 , vol. 15, # 22 p. 6994 - 7011

Full Text: HTML

Citation Number: 29

Abstract

Compound 1, 2-(benzo [1, 2, 5] thiadiazole-4-sulfonylamino)-5-chloro-N-(3, 4-dichloro- phenyl)-benzamide, was identified as a putative type III secretion inhibitor in Yersinia, and the compound thus has a potential to be used to prevent or treat bacterial infections. A set of seven analogues was synthesized and evaluated in a type III secretion dependent reporter- gene assay with viable bacterial to give basic SAR. A second set of 19 compounds was ...

Related Articles:

Cyclooxygenase-1-selective inhibitors are attractive candidates for analgesics that do not cause gastric damage. design and in vitro/in vivo evaluation of a benzamide- …

[Kakuta, Hiroki; Zheng, Xiaoxia; Oda, Hiroyuki; Harada, Shun; Sugimoto, Yukio; Sasaki, Kenji; Tai, Akihiro Journal of Medicinal Chemistry, 2008 , vol. 51, # 8 p. 2400 - 2411]

More Articles...